JP2023533504A5 - - Google Patents

Info

Publication number
JP2023533504A5
JP2023533504A5 JP2022581467A JP2022581467A JP2023533504A5 JP 2023533504 A5 JP2023533504 A5 JP 2023533504A5 JP 2022581467 A JP2022581467 A JP 2022581467A JP 2022581467 A JP2022581467 A JP 2022581467A JP 2023533504 A5 JP2023533504 A5 JP 2023533504A5
Authority
JP
Japan
Prior art keywords
seq
box
antibody
nos
polypeptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022581467A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023533504A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/040576 external-priority patent/WO2022010942A2/en
Publication of JP2023533504A publication Critical patent/JP2023533504A/ja
Publication of JP2023533504A5 publication Critical patent/JP2023533504A5/ja
Priority to JP2025173218A priority Critical patent/JP2026016462A/ja
Pending legal-status Critical Current

Links

JP2022581467A 2020-07-07 2021-07-06 バイオフィルムの処置および予防のための併用療法 Pending JP2023533504A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025173218A JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063049065P 2020-07-07 2020-07-07
US63/049,065 2020-07-07
US202163175487P 2021-04-15 2021-04-15
US63/175,487 2021-04-15
PCT/US2021/040576 WO2022010942A2 (en) 2020-07-07 2021-07-06 Combination therapies for the treatment and prevention of biofilms

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025173218A Division JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Publications (2)

Publication Number Publication Date
JP2023533504A JP2023533504A (ja) 2023-08-03
JP2023533504A5 true JP2023533504A5 (enExample) 2024-05-28

Family

ID=79553736

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022581467A Pending JP2023533504A (ja) 2020-07-07 2021-07-06 バイオフィルムの処置および予防のための併用療法
JP2025173218A Pending JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025173218A Pending JP2026016462A (ja) 2020-07-07 2025-10-14 バイオフィルムの処置および予防のための併用療法

Country Status (7)

Country Link
US (1) US20230272054A1 (enExample)
EP (1) EP4178359A4 (enExample)
JP (2) JP2023533504A (enExample)
CN (1) CN116096239B (enExample)
AU (1) AU2021305167A1 (enExample)
CA (1) CA3183196A1 (enExample)
WO (1) WO2022010942A2 (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN120230733B (zh) * 2025-06-03 2025-07-29 山东三元生物科技股份有限公司 一种基于Spytag/SpyCatcher环化修饰的蔗糖磷酸化酶突变体及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011123396A1 (en) * 2010-03-29 2011-10-06 University Of Southern California Compositions and methods for the removal of biofilms
US10722577B2 (en) * 2012-05-25 2020-07-28 Sloan Kettering Institute For Cancer Research Methods for treating GI syndrome and graft versus host disease
US20160340650A1 (en) * 2015-05-21 2016-11-24 Batu Biologics, Inc. Blood derived immune stimulatory compositions
EP3565589A1 (en) * 2017-01-04 2019-11-13 Research Institute at Nationwide Children's Hospital Dnabii vaccines and antibodies with enhanced activity
EP3595445B1 (en) * 2017-03-15 2024-09-04 The Research Institute at Nationwide Children's Hospital Composition and methods for disruption of bacterial biofilms without accompanying inflammation
US20210139610A1 (en) * 2018-06-29 2021-05-13 Research Institute At Nationwide Children's Hospital Compositions and methods for mediating eps
LT3841120T (lt) * 2018-08-21 2025-11-10 Antikūnai, surišantys citrulinuotą histoną 2a ir (arba) 4
JP2022504139A (ja) * 2018-10-05 2022-01-13 リサーチ インスティチュート アット ネイションワイド チルドレンズ ホスピタル バイオフィルムの除去のためのｈｍｇｂ１タンパク質誘導体
SG11202104120VA (en) * 2018-10-31 2021-05-28 Delinia Inc Multivalent regulatory t cell modulators
CA3145385A1 (en) * 2019-07-08 2021-01-14 Steven D. Goodman Antibody compositions for disrupting biofilms

Similar Documents

Publication Publication Date Title
JP2022036944A (ja) Ｒｇｍ ａタンパク質に対するモノクローナル抗体及びその使用
JP2024059791A (ja) 補体関連疾患のための融合タンパク質構築物
CN104870015B (zh) IL-1β的结合成员
KR102866306B1 (ko) 신경 성장 인자에 대한 단일 클론 항체, 및 이의 코딩 유전자 및 용도
US20050288491A1 (en) Super-humanized antibodies against respiratory syncytial virus
US20230257458A1 (en) Antibody of il-11 and use thereof
JP2011207882A5 (enExample)
US20160002343A1 (en) Blood-brain barrier (bbb) penetrating dual specific binding proteins for treating brain and neurological diseases
KR20150080033A (ko) 골관절염 및 통증의 치료 방법
CN101842388B (zh) 针对β淀粉样肽的人源化抗体
RU2007118670A (ru) Ангиопоэтин-2-специфические связывающие агенты
KR102558891B1 (ko) 항―ｉｌ４―ｉｌ１３ ２특이성 항체
KR20210015898A (ko) Nav1.7 모노클로날 항체
US20100297135A1 (en) Epitope for neutralizing antibodies
JP2022548646A5 (enExample)
TWI920062B (zh) 抗axl抗體及組合物
KR20260035744A (ko) 항-ne 항체 및 이를 포함하는 ne-과활성화 관련 질환의 예방 또는 치료용 약학적 조성물
US20250382356A1 (en) Anti-pcrv and psl bispecific antibodies for treatment of bronchiectasis
CN120554510B (zh) 抗钙粘蛋白-17的双表位抗体及采用其制备的抗体药物偶联物
CN118480121A (zh) 一种特异性结合金黄色葡萄球菌蛋白a的抗体及其应用
CN118459582A (zh) 一种抗焦谷氨酸修饰的β淀粉样蛋白抗体及其用途
CN120554506A (zh) 抗il-17a的纳米抗体及其制备方法和用途
EA052975B1 (ru) БИСПЕЦИФИЧЕСКИЕ АНТИТЕЛА К PcrV И Psl ДЛЯ ЛЕЧЕНИЯ БРОНХОЭКТАЗИИ
CN118019760A (zh) 抗IL-1-β抗体
HK1143983A (en) HUMANIZED ANTIBODIES AGAINST THE β-AMYLOYD PEPTIDE